CD28 and neoplasm: However, other evidence demonstrates that the tonic activation of CAR T-cells with the CD28 endo-domains is responsible for the suboptimal anti-tumor activity observed in vivo as the T cells exhaust rapidly, resulting into a decrease in cell proliferation and cytokine production [63].